Showing results (111-120 of 177) with videos related to
Sort By:
Pageof 18
Cancers|June 26, 2026
Pathological Predictors of Limited Salvage Radiotherapy Efficacy After Radical Prostatectomy: Central Review of JCOG0401Masashi Kato, Toyonori Tsuzuki, Akira Yokomizo, et al.Cancer Science|June 25, 2009
Expression of autotaxin and acylglycerol kinase in prostate cancer: association with cancer development and progressionMohammed Ahmed Abdel Muneem Nouh, Xiu-Xian Wu, Homare Okazoe, et al.Clinical and Experimental Nephrology|August 28, 2016
Impact of acute kidney injury defined by CTCAE v4.0 during first course of cisplatin-based chemotherapy on treatment outcomes in advanced urothelial cancer patientsRyutaro Ishitsuka, Jun Miyazaki, Daishi Ichioka, et al.International Journal of Clinical Oncology|March 8, 2025
Nomogram predicting the outcome of salvage radiation therapy for prostate-specific antigen failure following radical prostatectomy: an exploratory analysis of a randomized, multicenter, open-label, phase 3 trial (JCOG0401)Yoichiro Tohi, Akira Yokomizo, Takahiro Kimura, et al.European Urology Open Science|December 22, 2021
Comparison of Characteristics, Follow-up and Outcomes of Active Surveillance for Prostate Cancer According to Ethnicity in the GAP3 Global Consortium DatabaseKerri Beckmann, Aida Santaolalla, Jozien Helleman, et al.BMC Cancer|March 16, 2018
A comparison of nephrotoxicity between patients with a solitary-functioning kidney and those with bilateral-functioning kidneys in cisplatin-based chemotherapy for advanced urothelial carcinoma: a Japanese retrospective multi-institutional studyTakamitsu Inoue, Jun Miyazaki, Daishi Ichioka, et al.International Journal of Clinical Oncology|June 29, 2016
Current status of systemic chemotherapy for octogenarians with advanced urothelial cancer in Japan: a Japanese multi-institutional study (CURE study)Yoshiyuki Matsui, Osamu Ogawa, Ryutaro Ishitsuka, et al.Plos One|August 2, 2019
TP53 codon 72 polymorphism is associated with FGFR3 and RAS mutation in non-muscle-invasive bladder cancerTakashi Kawahara, Takahiro Kojima, Shuya Kandori, et al.International Journal of Clinical Oncology|May 20, 2022
Real-world analysis of apalutamide-associated skin adverse events in Japanese patients with advanced prostate cancer: a multi-institutional study in the Chu-shikoku Japan Urological ConsortiumYoichiro Tohi, Takuma Kato, Hideo Fukuhara, et al.International Journal of Clinical Oncology|June 9, 2026
Volume-adjusted p2PSA-derived indices for predicting prostate cancer: the PROPHET studyMasaki Shiota, Yoshitaka Sekine, Shoji Tokunaga, et al.Pageof 18